Sanofi (SNY) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à Paris, France. Le PDG actuel est Olivier Charmeil.
SNY a date d'introduction en bourse 2002-07-01, 82,878 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $116.02B.
Sanofi is a Paris-based pharmaceutical and healthcare company that researches, develops, manufactures, and markets a comprehensive range of therapeutic solutions globally. The company operates through three primary segments: Pharmaceuticals, Vaccines, and Consumer Healthcare, offering specialty care products for conditions including multiple sclerosis, immunology, rare diseases, oncology, and diabetes, alongside a broad portfolio of pediatric and adult vaccines covering poliomyelitis, influenza, meningitis, and other endemic diseases. Sanofi also provides consumer health products spanning allergy relief, pain management, digestive wellness, and dermatological care. The company maintains strategic collaborations with leading institutions, including GlaxoSmithKline for COVID-19 vaccine development and Stanford University School of Medicine for immunology research, positioning itself as a diversified leader in both prescription pharmaceuticals and preventive healthcare.
